Banner

News

Video

Compounded GLP-1 RA drugs: Criteria for compounding medicines to fill gaps that drugmakers can’t fill

Author(s):

Richard Payerchin

Fact checked by:

Todd Shryock

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

There are three criteria for compounding pharmacists to mix a version of a medicine that is not available from a pharmaceutical manufacturer. Scott Brunner, CEO of the Alliance for Pharmacy Compounding offers this tutorial and examples of how compounding pharmacists meet patient demand for necessary drugs.

Related Videos
Related Content
Primary care on the front lines of the youth mental health crisis © Liubomir - stock.adobe.com
May 20th 2025

Primary care on the front lines of the youth mental health crisis

Off the Chart: A Business of Medicine Podcast - Ep. 65: Patient autonomy with Jeffrey A. Singer, M.D.
May 19th 2025

Ep. 65: Patient autonomy with Jeffrey A. Singer, M.D.

In Medicare Advantage value-based care, women PCPs outperform and outearn their male peers © makyzz - stock.adobe.com
May 19th 2025

In Medicare Advantage value-based care, women PCPs outperform and outearn their male peers

Zed Williamson and the Physician Growth Accelerator Podcast featured on Medical Economics
May 15th 2025

Vague goals are derailing your medical practice

© Inovalon
May 16th 2025

The link between revenue cycle management and mental health patients’ well-being

medicaid website view: © Postmodern Studio - stock.adobe.com
May 16th 2025

Medicaid spending, effects on health care at heart of federal budget debate